Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Malzahn

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
BMC Infectious Diseases|January 6, 2024
Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)Caroline Tengelmann, Stefanie Joos, Yvonne Kaußner, et al.
Biochemical and Biophysical Research Communications|October 22, 2021
Protective effects of spironolactone on vascular calcification in chronic kidney diseaseFabian Hammer, Salvatore S Buehling, Jaber Masyout, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2016
Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - The PREDICT studySarah Hoffmann, Hendrik Harms, Lena Ulm, et al.
Neurology|July 21, 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationEleni Korompoki, Filippos T Filippidis, Peter B Nielsen, et al.
The New England Journal of Medicine|August 2, 2018
A Copeptin-Based Approach in the Diagnosis of Diabetes InsipidusWiebke Fenske, Julie Refardt, Irina Chifu, et al.
Neurological Research and Practice|February 11, 2025
Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulationRoland Veltkamp, Kirsten Haas, Viktoria Rücker, et al.
Child and Adolescent Psychiatry and Mental Health|October 14, 2025
Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trialRegina Taurines, Manfred Gerlach, Christoph U Correll, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 2, 2024
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance studyJessica Riegger, Karin Maria Egberts, Hans-Willi Clement, et al.
Thrombosis and Haemostasis|December 31, 2024
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF TrialEleni Korompoki, Peter Heuschmann, Kirsten H Harvey, et al.
Pharmacopsychiatry|February 7, 2022
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical PracticeKarin M Egberts, Manfred Gerlach, Christoph U Correll, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|January 6, 2024
Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)Caroline Tengelmann, Stefanie Joos, Yvonne Kaußner, et al.
Biochemical and Biophysical Research Communications|October 22, 2021
Protective effects of spironolactone on vascular calcification in chronic kidney diseaseFabian Hammer, Salvatore S Buehling, Jaber Masyout, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2016
Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - The PREDICT studySarah Hoffmann, Hendrik Harms, Lena Ulm, et al.
Neurology|July 21, 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillationEleni Korompoki, Filippos T Filippidis, Peter B Nielsen, et al.
The New England Journal of Medicine|August 2, 2018
A Copeptin-Based Approach in the Diagnosis of Diabetes InsipidusWiebke Fenske, Julie Refardt, Irina Chifu, et al.
Neurological Research and Practice|February 11, 2025
Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulationRoland Veltkamp, Kirsten Haas, Viktoria Rücker, et al.
Child and Adolescent Psychiatry and Mental Health|October 14, 2025
Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trialRegina Taurines, Manfred Gerlach, Christoph U Correll, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 2, 2024
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance studyJessica Riegger, Karin Maria Egberts, Hans-Willi Clement, et al.
Thrombosis and Haemostasis|December 31, 2024
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF TrialEleni Korompoki, Peter Heuschmann, Kirsten H Harvey, et al.
Pharmacopsychiatry|February 7, 2022
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical PracticeKarin M Egberts, Manfred Gerlach, Christoph U Correll, et al.
Pageof 7